Navigation Links
Anemia treatment may be a double-edged sword
Date:1/30/2008

Erythropoietin has so far been known to doctors as a hormone that boosts red-blood-cell production. Now, a mouse study led by Lois Smith, MD, PhD, an ophthalmologist at Children's Hospital Boston, shows it also keeps blood vessels alive and growing in the eye. The findings not only add a new function to the hormone, but also give doctors a reason to pause before prescribing it to patients with diseases affected by abnormal blood-vessel growth, such as retinopathy and cancer.

The study, published in the February issue of the Journal of Clinical Investigation (online January 24), also found that whether the hormone is a risk or benefit depends on the timing of administration.

Smith and first author Jing Chen, PhD, worked in mice with retinopathy, an eye disease that begins when healthy blood vessels nourishing the retina die. Numerous vessels then grow in, but they are deformed. Ultimately, the deformed vessels may pull the retina off the back of the eye, causing blindness.

The researchers measured erythropoietin produced in the retina as the disease progressed. Production was 3 to 10 times below normal during early-stage retinopathy, when healthy blood vessels died, and 12 to 33 times above normal during late-stage retinopathy, when deformed blood vessels grew into the retina. The researchers concluded that erythropoietin helps blood vessels survive and grow in the retina, with effects that may be healthy or harmful.

Next, the team examined whether giving erythropoietin could treat retinopathy. They injected erythropoietin into the bloodstream either early, as the mice lost healthy blood vessels, or later, when deformed blood vessels began to invade--then compared them with untreated mice.

Boosting erythropoietin early slowed the disease. The mice lost half as many healthy blood vessels, causing about 30 percent fewer deformed vessels to grow in. Raising erythropoietin levels later, when deformed
'/>"/>

Contact: Keri Stedman
keri.stedman@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. FDA Reports New Risks Posed by Anemia Drugs
2. Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
3. Evidence links anemia drugs with leukemic transformation in patients with primary myelofibrosis
4. New Kind of Stem Cells Reverse Sickle Cell Anemia
5. FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
6. New anemia measure predicts risk of death in dialysis patients
7. FDA Issues New Warnings for Anemia Drugs
8. Simpler Anemia Treatment May Help Kidney Patients
9. Cancer Doctors Across America Stunned at Governments Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling Interference in Practice of Medicine
10. Controversial Anemia Drug Doesnt Cut Need for Transfusions
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized a ... learned through meditation and initiation at Special Holistic School ... Yogamaatha, a nine-year-old girl from North Carolina, stunned an ... the 2015 Business Advocacy Summit at Capitol Hill in ... In a demonstration that lasted three hours, Yogamaatha was ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The American ... exciting events in June. They will hold a webinar ... and a two-day class on Classical Chinese Medicine. , ... 3, Dr. Steve Given, the Dean of Clinical Education, ... the new First Professional Doctorate program. ACTCM is currently ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health Limited has ... Nature’s Way, Marc St-Onge has affirmed his commitment to ... an integral part of the agreement with Nature’s Way ... develop Ascenta Skin into a leading player in the ... anti-aging skincare supplement featuring 6 active ingredients including therapeutic ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... A Michigan State University surgeon is teaming up with ... create a simple, cost-effective saliva test to detect oral cancer, ... fewer people dying of the world,s sixth most common cancer. ... Medicine,s Department of Surgery and lead investigator on the project, ...
... TUESDAY, April 17 (HealthDay News) -- The ability to make ... changes in the brain,s white matter, a new imaging study ... 85, to perform a learning task involving money and also ... in decision-making are associated with the weakening of two specific ...
... Mothers with depression may behave in ways that disturb their ... University researchers conducted home visits with 45 mothers and their ... over 7 consecutive days to collect information about depression symptoms ... Greater amounts of sleep disruption were noted in infants whose ...
... TUESDAY, April 17 (HealthDay News) -- New research adds to ... (protein) plaques, the brain-clogging fragments that have been associated with ... Healthcare Berlin, researchers report that they were able to use ... the brains of patients whose Alzheimer,s was confirmed after death. ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) -- ... appear to get no survival benefit from adding the ... Cancer Institute report. An earlier trial had found ... patients aged 65 and older. Even so, the researchers ...
... drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small ... FDA in 2006 did not lead to significantly increase ... in Medicare, a new study by Dana-Farber Cancer Institute researchers ... April 18 Journal of the American Medical Association , ...
Cached Medicine News:Health News:Saliva test could dramatically increase detection of oral cancer 2Health News:Depressed Moms May Hinder Babies' Sleep 2Health News:New Method to Reveal Alzheimer's Marker Shows Promise 2Health News:Avastin No Benefit to Older Lung Cancer Patients: Study 2Health News:Avastin No Benefit to Older Lung Cancer Patients: Study 3Health News:Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients 2
(Date:5/22/2015)... May 22, 2015  The Mesothelioma Victims Center ... of mesothelioma get the best possible compensation, and they ... with this rare cancer caused by exposure to ... information related to treatment options such as a ... the Mesothelioma Victims Center anytime at 866-714-6466. ...
(Date:5/22/2015)... , May 22, 2015 Today, Rhodes ... nervous system stimulant indicated for the treatment of ... beginning Summer 2015. The announcement ... approval from the U.S. Food and Drug Administration ... extended-release formulation of methylphenidate capsule with an onset ...
(Date:5/21/2015)... 2015 Research and ... addition of the "North American Joint ... Replacement, Elbow Replacement, Hip Replacement, Knee Replacement, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... valued at $4,470.9 million in 2014 and ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... Sept. 7, 2011 Prescription monitoring laboratory and ... comprehensive program, its Safe Use Treatment Monitoring Solution™. ... Use is compliant with the FDA,s Opioid Risk ... Prescribing Regulations for controlled substances.  The program aims ...
... MARY, Fla., Sept. 7, 2011 PediaVision today announced ... children across America.  This revolutionary new technology, Spot ... accuracy and deliver immediate comprehensive results.   ... of less than one second which makes ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot 2PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot 3PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot 4
... with 96-well plates in mind, Pipetman ... molecular biology applications: PCR* sequencing, immunology ... etc. Used with Diamond Tips from ... product will maximize performance and assure ...
... Finnpipette Focus multichannel ... dispensing of reagents into ... for 0.1-10 l volumes. ... of Finnpipette Focus multichannels, ...
... Long series in colonies, rows, and microplatesthat ... the multichannel pipette is becoming an ever-increasing ... use) was the main reason that the ... 8- or 12-channel pipette provides effective, precise, ...
... Focus multichannel pipettes speed ... reagents into microplates, with ... l volumes. The improved ... Focus multichannels, combined with ...
Medicine Products: